Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
Resmed Inc has filed a definitive proxy statement with the United States Securities and Exchange Commission, indicating no fee is required for this filing. This filing is part of the company’s compliance with the Securities Exchange Act of 1934, and it does not appear to have immediate implications for the company’s operations or stakeholders.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$47.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,037,884
Technical Sentiment Signal: Buy
Current Market Cap: A$59.91B
See more data about RMD stock on TipRanks’ Stock Analysis page.